36
Participants
Start Date
August 17, 2023
Primary Completion Date
March 7, 2028
Study Completion Date
March 7, 2028
XGEVA®
Participants will receive XGEVA® 120 mg subcutaneously (SC) once every 4 weeks (Q4W) with a loading dose of 120 mg SC on day 8 and day 15.
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Beijing Jishuitan Hospital, Beijing
Peking University Peoples Hospital, Beijing
Harbin Meidical University Cancer Hospital, Harbin
The Second Affiliated hospital of Zhejiang University School of Medicine, Hangzhou
The First Affiliated Hospital of Fujian Medical University, Fuzhou
The Third Affiliated Hospital Of Southern Medical University, Guangzhou
Sun Yat-sen University Cancer Center, Guangzhou
Tangdu Hospital of Air Force Medical University, Xi'an
Lead Sponsor
Amgen
INDUSTRY